Research on Pharmacotherapy of Metabolic-Associated Fatty Liver Disease

A special issue of Metabolites (ISSN 2218-1989). This special issue belongs to the section "Pharmacology and Drug Metabolism".

Deadline for manuscript submissions: 30 September 2024 | Viewed by 130

Special Issue Editor

E-Mail Website
Guest Editor
Department of Internal Medicine and Clinical Pharmacology, Medical University of Silesia, Medykow 18, 40-752 Katowice, Poland
Interests: pharmacotherapy; gastroenterology; hepatology

Special Issue Information

Dear Colleagues,

This special issue will delve into liver diseases, specifically focusing on the pharmacotherapy of Metabolic-Associated Fatty Liver Disease (MAFLD). Encompassing viral infections and metabolic disorders falling (after nomenclature change in June 2023 during EASL conference) under the umbrella term SLD (Steatotic Liver Disease), including Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Metabolic Alcohol-Related Liver Disease or Drug-Induced Liver Injury (DILI), it highlights the crucial role of metabolomics in understanding liver conditions. Authors are encouraged to investigate disruptions in both endogenous and exogenous metabolites, utilizing advanced techniques like lipidomics, cheminformatics, and computational chemistry. The issue underscores the significance of metabolomics in offering insights for early diagnosis, steering targeted therapies, and cultivating a profound understanding of metabolic dysregulation in hepatic disorders.

Dr. Aleksandra Bołdys
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Metabolites is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.


  • liver diseases
  • metabolomics
  • metabolic diseases
  • metabolic dysregulation
  • targeted therapies

Published Papers

This special issue is now open for submission.
Back to TopTop